Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies

American Heart Journal

Volumn 159, Issue 5, 2010, Pages 864-870

  Buxbaum, Joel ^a   Alexander, Alice ^b   Koziol, James ^a   Tagoe, Clement ^c   Fox, Ervin ^d   Kitzman, Dalane ^e  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ISOLEUCINE; PREALBUMIN; VALINE;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HEART AMYLOIDOSIS; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PENETRANCE; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; FEMALE; GENE FREQUENCY; HEART DISEASES; HUMANS; ISOLEUCINE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MUTATION; PREALBUMIN; VALINE;

EID: 77951551396     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.02.006     Document Type: Article

References (38)

1. Buck F.S., Koss M.N., Sherrod A.E., et al. Ethnic distribution of amyloidosis: an autopsy study. Mod Pathol 2 (1989) 372-377
2. Gorevic P.D., Prelli F.C., Wright J., et al. Systemic Senile Amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 83 (1989) 836-843
3. Jacobson D.R., Gorevic P.D., and Buxbaum J.N. A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology. Am J Hum Genet 47 (1990) 127-136
4. Jiang X., Buxbaum J.N., and Kelly J.W. The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis. Proc Natl Acad Sci U S A 98 (2001) 14943-14948
5. Asl K.H., Nakamura M., Yamashita T., et al. Cardiac amyloidosis associated with the transthyretin Ile122 mutation in a Caucasian family. Amyloid 8 (2001) 263-269
6. Jacobson D.R., Pastore R.D., Yaghoubian R., et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 336 (1997) 466-473
7. Buxbaum J., Jacobson D.R., Tagoe C., et al. Transthyretin V122I in African Americans with congestive heart failure. J Am Coll Cardiol 47 (2006) 1724-1725
8. Connors L.H., Prokaeva T., Lim A., et al. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J 158 (2009) 607-614
9. Fried L.P., Borhani N.O., Enright P., et al. The cardiovascular health study: design and rationale. Ann Epidemiol 1 (1991) 263-276
10. Furberg C.D., Manolio T.A., Psaty B.M., et al. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. Am J Cardiol 69 (1992) 1329-1335
11. Gardin J.M., Wong N.D., Bommer W., et al. Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. J Am Soc Echocardiogr 5 (1992) 63-72
12. Investigators ARIC. The atherosclerosis risk in communities (ARIC) study: design and objectives. Am J Epidemiol 129 (1989) 687-702
13. Vitelli L., Crow R., Shahar E., et al. Electrocardiographic Findings in a Healthy Biracial Population. Am J Cardiol 81 (1998) 453-459
14. Fox E.R. The prognostic value of the mitral diastolic filling velocity ratio for all-cause mortality and cardiovascular morbidity in African Americans: the Atherosclerotic Risks in Communities (ARIC) study. Am Heart J 152 (2006) 749-755
15. Skelton T.N., Andrew M.E., Arnett D.K., et al. Echocardiographic left ventricular mass in African-Americans: the Jackson cohort of the Atherosclerosis Risk in Communities Study. Echocardiography 20 (2003) 111-120
16. Aurigemma G.P., Gottdiener J.S., Shemanski L., et al. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 37 (2001) 1042-1048
17. Drazner M.H., Rame J.M., Marion P., et al. Increased Left Ventricular Mass is a risk factor for the development of a depressed left ventricular ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol 43 (2004) 2207-2215
18. Gardin J.M., McClelland R., Kitzman D.W., et al. M-mode echocardiographic predictors of six-to-seven year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort: the Cardiovascular Health Study. Am J Cardiol 87 (2001) 1051-1057
19. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35 (2000) 1628-1637
20. Gottdiener J.S., McClelland R., Marshall R.J., et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 137 (2002) 631-639
21. Gottdiener J.S., Kitzman D.W., Aurigemma G.P., et al. Left Atrial Volume, Geometry, and Function in Systolic and Diastolic Heart Failure of Persons >=65 Years of Age (The Cardiovascular Health Study). Am J Cardiol 97 (2006) 83-89
22. Kitzman D.W., Gardin J.M., Gottdiener J.S., et al. Importance of heart failure with preserved systolic function in patients > or = 65 Years of Age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 87 (2001) 413-419
23. Liao L., Anstrom K.J., Gottdiener J.S., et al. Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study. Am Heart J 153 (2007) 245-252
24. Mathew S.T., gottdiener J.S., Kitzman D.W., et al. Congestive heart failure in the elderly: the Cardiovascular Health Study. Am J Geriatr Cardiol 13 (2004) 61-68
25. Jacobson D.R. A specific test for transthyretin 122 (Val-Ile) based on PCR-primer introduced restriction analysis (PCR-PIRA): confirmation of the gene frequency in Blacks. Am J Hum Genet 50 (1992) 195-198
26. Alexander A., Subramanian N., Buxbaum J.N., et al. Drop-in, drop-out allele-specific PCR: a highly sensitive, single-tube method. Mol Biotechnol 28 (2004) 171-174
27. Psaty B.M., Kuller L.H., Bild D.E., et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 5 (1995) 270-277
28. Koyama J., Ray-Sequin P.A., and Falk R.H. Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation 106 (2002) 556-561
29. Falk R.H., Plehn J.F., Deering T., et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 59 (1987) 418-422
30. Falk R.H. Diagnosis and management of the cardiac amyloidoses. Circulation 112 (2005) 2047-2060
31. Reiner A.P., Ziv E., Lind D.L., et al. Population structure, admixture, and aging-related phenotypes in African American adults: the Cardiovascular Health Study. Am J Hum Genet 76 (2005) 463-477
32. Koyama J., Ray-Sequin P.A., Davidoff R., et al. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 89 (2002) 1067-1071
33. Koyama J., Ray-Sequin P.A., and Falk R.H. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107 (2003) 2446-2452
34. Gertz M.A., Skinner M., Connors L.G., et al. Selective binding of nifedipine to amyloid fibrils. Am J Cardiol 55 (1985) 1646
35. Gertz M.A., Falk R.H., Skinner M., et al. Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents. Am J Cardiol 55 (1985) 1845
36. Rubinow A., Skinner M., and Cohen A.S. Digoxin sensitivity in amyloid cardiomyopathy. Circulation 63 (1981) 1285-1288
37. Parikh S., and de Lemos J. Current therapeutic strategies in cardiac amyloidosis. Curr Treat Options Cardiovasc Med 7 (2005) 443-448
38. Adamski-Werner S.L., Palaninathan S.K., Sacchettini J.C., et al. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis. J Med Chem 47 (2004) 355-374